Latest News

"First Patient Treated in Trillium's Interstitial Cystitis/Bladder Pain Syndrome Clinical Trial" go »

For information on Trillium's interstitial cystitis/bladder pain syndrome clinical study click here

 
Trillium Therapeutics Inc. (TTI) is a private research and development biopharmaceutical company with two main areas of focus: cytoprotection and immune regulation.